About Delsys Pharmaceutical Corporation
Delsys Pharmaceutical Corporation is a company based in Monmouth Junction (United States) founded in 1977 was acquired by Elan in September 2001.. Delsys Pharmaceutical Corporation has raised $40 million across 2 funding rounds from investors including Elan, International Biotechnology Trust and Healthcare Ventures. Delsys Pharmaceutical Corporation operates in a competitive market with competitors including Eurofins Scientific, WuXi AppTec, Ipsen, CHEPLAPHARM and ANI Pharmaceuticals, among others.
- Headquarter Monmouth Junction, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Delsys Pharmaceutical Corporation
Delsys Pharmaceutical Corporation has successfully raised a total of $40M across 2 strategic funding rounds. The most recent funding activity was a Private Equity Round round of $26 million completed in April 2000. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Private Equity Round — $26.0M
-
First Round
First Round
(14 Sep 1998)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2000 | Amount | Private Equity Round - Delsys Pharmaceutical Corporation | Valuation |
investors |
|
| Sep, 1998 | Amount | Private Equity Round - Delsys Pharmaceutical Corporation | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Delsys Pharmaceutical Corporation
Delsys Pharmaceutical Corporation has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Elan, International Biotechnology Trust and Healthcare Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment opportunities in biotechnology are facilitated by this trust.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Early-stage tech startups are invested in by Rho Capital Partners.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Delsys Pharmaceutical Corporation
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Delsys Pharmaceutical Corporation
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Delsys Pharmaceutical Corporation Comparisons
Competitors of Delsys Pharmaceutical Corporation
Delsys Pharmaceutical Corporation operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Eurofins Scientific, WuXi AppTec, Ipsen, CHEPLAPHARM and ANI Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Laboratory testing and contract research services are provided globally.
|
|
| domain | founded_year | HQ Location |
Provider of CRO and CDMO services
|
|
| domain | founded_year | HQ Location |
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes
|
|
| domain | founded_year | HQ Location |
Branded pharmaceutical products are developed, marketed, and distributed globally.
|
|
| domain | founded_year | HQ Location |
Branded and generic prescription drugs are developed, manufactured, and marketed.
|
|
| domain | founded_year | HQ Location |
CRO focused on clinical development for phases II & III clinical trials and regulatory affair services
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Delsys Pharmaceutical Corporation
When was Delsys Pharmaceutical Corporation founded?
Delsys Pharmaceutical Corporation was founded in 1977 and raised its 1st funding round 21 years after it was founded.
Where is Delsys Pharmaceutical Corporation located?
Delsys Pharmaceutical Corporation is headquartered in Monmouth Junction, United States. It is registered at Monmouth Junction, New Jersey, United States.
Who is the current CEO of Delsys Pharmaceutical Corporation?
David King is the current CEO of Delsys Pharmaceutical Corporation.
Is Delsys Pharmaceutical Corporation a funded company?
Delsys Pharmaceutical Corporation is a funded company, having raised a total of $40M across 2 funding rounds to date. The company's 1st funding round was a Private Equity Round of $14M, raised on Sep 14, 1998.
What does Delsys Pharmaceutical Corporation do?
Delsys Pharmaceutical Corporation was focused on developing proprietary technology to enhance pharmaceutical formulation development and manufacture and drug delivery. It leverages its proprietary Accudep technology which is a controlled electrostatic powder deposition process that permits a drugs active ingredient to be deposited in precise quantities at high speed onto a variety of surfaces. It claims that the technology has benefits such as improved drug quality and safety, reduced time to market and an overall reduction in manufacturing costs and infrastructure-intensive process associated with traditional pharmaceutical manufacturing. In September 2001, Elan acquired Delsys and its technology for around 50M.
Who are the top competitors of Delsys Pharmaceutical Corporation?
Delsys Pharmaceutical Corporation's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.
Who are Delsys Pharmaceutical Corporation's investors?
Delsys Pharmaceutical Corporation has 7 investors. Key investors include Elan, International Biotechnology Trust, Healthcare Ventures, Rho Capital Partners, and Prism Venture Partners.